MPN Advocates Network (MPN AN) operates for the benefit of MPN patients and acts independently of any other organization or company. The organisation is constituted as an independent steering committee within a parent organisation, the Leukaemia Patient Advocates Foundation, registered as a non-profit organisation in Switzerland. MPN AN has it’s own scientific advisory board.

Our Mission
The mission of the MPN Advocates Network is to enhance the ability of global patient advocacy organizations to improve:

• Patient care
• Quality of life
• Patient empowerment

for all patients who have been diagnosed with myeloproliferative neoplasms (MPN) and their caregivers.

Our Vision
Our vision, quite simply, is a world without MPNs.

Funding
MPN AN receives support from a broad base of sponsors and diversified funding sources. Our funding for the activities comes from the variety of sources including pharmaceutical companies and philanthropy.

– Steering Committee –

 

Chairperson	Treasurer
Werner Zinkand MPN-Netzwerk Germany	Param Puthen Friends of Max, India

 

Felice Bombaci Gruppo AIL Pazienti LMC, Italy	Lyat Granati Espinosa Max Foundation, Chile

 

Jon Mathias MPN Voice, UK	Giora Sharf LePaf Representative and Israeli Flute of Light Patients Organization, Israel

 

Ken Young MPN Alliance, Australia	Kapila Viges MPN Research Foundation, USA

Dražen Vincek
Croatian Leukemia and Lymphoma Society (HULL), Croatia

– Management Team –  
Marija Stefkova
Macedonia
email: doneva@mpn-advocates.net